Report found business relationships between telehealth and pharma companies may indirectly lead patients toward certain ...

Pfizer should have different top-selling drugs in 2030 with a heavier focus on oncology. The drugmaker should be more ...

Bristol Myers and Pfizer will sell Eliquis directly to U.S. patients at a discounted rate with transparent pricing and nationwide delivery.

Sales of Oncology rose 27% to $3.96 billion. Primary Care In Primary Care, alliance revenues and direct sales from Bristol-Myers BMY for blood-thinning treatment Eliquis rose 8% to $1.88 billion.

Pharmaceutical giants introduce an insurance-free pathway for top anticoagulant Eliquis, following similar direct-to-patient ...

Pfizer (PFE), in collaboration with Bristol Myers Squibb, has introduced a direct-to-patient option for Eliquis®, potentially enhancing patient access and affordability. Over the past quarter ...

The program is the latest example of pharmaceutical companies bypassing traditional drug distribution channels for people who ...

The direct-to-consumer (DTC) platform – called Eliquis 360 Support – will offer Eliquis (apixaban) to patients who pay for ...

However, sales could be hurt by lower pricing in the United States. The Zacks Consensus Estimate for alliance revenues from Eliquis is $2.0 billion, while our model estimate is $2.28 billion.